Open Beta
MetriLume

US marketsGOSS

SEC-sourced researchBeta

GOSS

Gossamer Bio, Inc.

Company comparison ↗

Data passport

CIK
0001728117
Exchange
Nasdaq
Business activity
— · SIC 2834
Financial inputs
6/6
Filing date
Sep 28, 2026
SEC registry record
Operating company

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2023: 0.0000 USD; December 2024: 114,701,000.0000 USD; December 2025: 48,471,000.0000 USD114.7M USD0 USD0December 2023December 2024December 2025
GOSS · Exact amounts and source periods · USD
Period endRevenueFiling date
December 20230.0000Mar 17, 2026
December 2024114,701,000.0000Mar 17, 2026
December 202548,471,000.0000Mar 17, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 202548,471,000.0000-170,370,000.0000-171,266,000.0000172,249,000.0000295,009,000.0000Mar 17, 2026
December 2024114,701,000.0000-56,528,000.0000-3,468,000.0000315,292,000.0000285,800,000.0000Mar 17, 2026
December 20230.0000-179,817,000.0000-159,158,000.0000——Mar 17, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$48.47MDecember 2025Mar 17, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$114.7MDecember 2024Mar 17, 202610-K
Net incomeNetIncomeLoss-$170.37MDecember 2025Mar 17, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$171.27MDecember 2025Mar 17, 202610-K
Total assetsAssets$172.25MDecember 2025Mar 17, 202610-K
Total liabilitiesLiabilities$295.01MDecember 2025Mar 17, 202610-K

New filings

Explore methodology ↗